Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
26 results
D1.437 - A Decade of Research on Janus Kinase Inhibitors in Atopic Dermatitis: A Global Bibliometric Analysis (2015–2024)
D1.438 - Dupilumab for Moderate-to-Severe Atopic Dermatitis in Children and Adolescents: Real-Life Assessment of Efficacy and Safety
D1.442 - Design and Preclinical Development of a Bispecific Antibody Targeting IL11 and TL1A
D1.443 - Preclinical Development of a Dual LIGHT/TL1A Bispecific Antibody
D1.447 - Comparison of Disease Duration, Remission, and Other Disease-Related Parameters with the Duration of Omalizumab Treatment in Patients with Chronic Spontaneous Urticaria
D1.448 - Long-Term Efficacy and Stability of Lebrikizumab in Treating Face/Head and Neck Involvement in Patients with Moderate-to-Severe Atopic Dermatitis
D1.449 - A Phase 2, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Briquilimab in Adults with Chronic Urticaria (Trial in Progress)
D1.439 - Urticaria Voices: Physician-reported perspectives of chronic urticaria care and its treatment in China (UV in China)
D3.51 - Cardiovascular System Problems in Children Athletes with Allergic Diseases
D3.59 - Occupational Cobalt Contact Dermatitis: Clinical Profile and Work implications
D3.52 - Clinical spectrum and diagnostic challenges of paediatric angioedema without wheals
D3.55 - Hereditary angioedema with normal C1-INH: DAB2IP mutation report
D3.56 - Investigation of Serum Eosinophilic Granule Proteins Levels in Children with Chronic Spontaneous Urticaria
D3.58 - Eosinophilic ascites and extreme hypereosinophilia: differential diagnosis through medical treatment
D3.60 - Allergic reaction in bisoprolol overdose
D3.61 - Acquired Food Allergy After Allogeneic Hematopoietic Stem Cell Transplantation From a Non-Allergic Unrelated Donor
D3.62 - Application of a logistic regression model to predict the risk of allergic reactions in children with salmon sensitization (Sal s 1)
D3.50 - Molecular Characterization of Allergen Sensitization and Clinical Associations in a Romanian Cohort Using ALEX² Multiplex Assay
D3.232 - The AhR agonist tapinarof suppresses human skin inflammation by inducing metabolic reprogramming and reducing production of mitochondrial pro-inflammatory DAMPs
D3.231 - Gut Microbiome Dysbiosis in Antihistamine-Refractory Chronic Spontaneous Urticaria and Its Association with Disease Characteristics- A Cross-Sectional Case–Control Analysis
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download